Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-023777
Filing Date
2013-04-25
Accepted
2013-04-25 10:30:12
Documents
18
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F v342424_20f.htm 20-F 1277751
2 EXHIBIT 10.54 v342424_ex10-54.htm EX-10.54 33350
3 EXHIBIT 10.55 v342424_ex10-55.htm EX-10.55 77258
4 EXHIBIT 10.56 v342424_ex10-56.htm EX-10.56 41751
5 EXHIBIT 10.57 v342424_ex10-57.htm EX-10.57 111056
6 EXHIBIT 10.58 v342424_ex10-58.htm EX-10.58 55758
7 EXHIBIT 10.59 v342424_ex10-59.htm EX-10.59 140166
8 EXHIBIT 10.60 v342424_ex10-60.htm EX-10.60 90423
9 EXHIBIT 10.61 v342424_ex10-61.htm EX-10.61 758250
10 EXHIBIT 21.1 v342424_ex21-1.htm EX-21.1 3596
11 EXHIBIT 23.2 v342424_ex23-2.htm EX-23.2 3288
12 EXHIBIT 23.3 v342424_ex23-3.htm EX-23.3 2199
13 EXHIBIT 31.1 v342424_ex31-1.htm EX-31.1 7444
14 EXHIBIT 31.2 v342424_ex31-2.htm EX-31.2 7396
15 EXHIBIT 32.1 v342424_ex32-1.htm EX-32.1 5222
16 GRAPHIC tpg44.jpg GRAPHIC 44846
17 GRAPHIC tpicex10-61.jpg GRAPHIC 4299
18 GRAPHIC tline.jpg GRAPHIC 2779
  Complete submission text file 0001144204-13-023777.txt   2687880
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 20-F | Act: 34 | File No.: 000-51310 | Film No.: 13781382
SIC: 2834 Pharmaceutical Preparations